SONM
DNA X·NASDAQ
--
--(--)
--
--(--)
SONM fundamentals
DNA X (SONM) released its earnings on Oct 31, 2025: revenue was 16.21M (YoY +7.94%), missed estimates; EPS was -4.83 (YoY +48.40%), missed estimates.
Revenue / YoY
16.21M
+7.94%
EPS / YoY
-4.83
+48.40%
Report date
Oct 31, 2025
EPS
Actual | -864 | -396 | -180 | -180 | -252 | -180 | -235.8 | -68.4 | -7.2 | 1.8 | -5.4 | -12.6 | -25.38 | -9.36 | -81 | 1.44 | -14.22 | -4.83 | |||||
Forecast | -552 | -420 | -324 | -234 | -180 | -180 | -108 | -90 | -36 | 1.8 | -5.4 | -9.72 | -11.88 | -7.2 | -2.34 | 0.72 | 5.4 | ||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | -56.52% | +5.71% | +44.44% | +23.08% | -40.00% | 0.00% | -118.33% | +24.00% | +80.00% | 0.00% | 0.00% | -400.00% | -133.33% | -161.11% | +21.21% | -1025.00% | +161.54% | -2075.00% | -189.44% |
Revenue
Actual | -- | -- | -- | -- | 12.71M | 21.06M | 14.39M | 15.80M | 12.24M | 11.95M | 14.45M | 13.26M | 20.50M | -- | 27.57M | 13.40M | 16.78M | 11.50M | 15.02M | 15.00M | 16.72M | 11.20M | 16.21M |
Forecast | -- | -- | -- | -- | 16.13M | 14.90M | 18.17M | 14.50M | 12.97M | 14.07M | 16.05M | 20.50M | 25.50M | -- | -- | 27.57M | 18.00M | 10.91M | 14.78M | 19.55M | 25.41M | 29.17M | 34.34M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | -21.24% | +41.33% | -20.77% | +8.97% | -5.60% | -15.02% | -10.00% | -35.33% | -19.62% | 0.00% | 0.00% | -51.39% | -6.80% | +5.39% | +1.63% | -23.29% | -34.20% | -61.60% | -52.79% |
Earnings Call
You can ask Aime
What guidance did DNA X's management provide for the next earnings period?What is the market's earnings forecast for DNA X next quarter?What is the revenue and EPS growth rate for DNA X year over year?What were the key takeaways from DNA X's earnings call?What does DNA X do and what are its main business segments?What is DNA X's latest dividend and current dividend yield?What were the key takeaways from DNA X’s earnings call?What is DNA X's gross profit margin?
